Related references
Note: Only part of the references are listed.Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers - Results of a large scale microarray analysis
Achim Rody et al.
EUROPEAN JOURNAL OF CANCER (2009)
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability
Martin H. van Vliet et al.
BMC GENOMICS (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice
F. Dahm et al.
BRITISH JOURNAL OF CANCER (2008)
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
Eugen Ruckhaeberle et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
Andrew E. Teschendorff et al.
BREAST CANCER RESEARCH (2008)
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
Fabien Reyal et al.
BREAST CANCER RESEARCH (2008)
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
Gabricla Alexe et al.
CANCER RESEARCH (2007)
Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC):: Attenuation C18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis
Serdar Karahatay et al.
CANCER LETTERS (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
Lung metastasis genes couple breast tumor size and metastatic spread
Andy J. Minn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression pro-filing study
Yun Gong et al.
LANCET ONCOLOGY (2007)
Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1
Achim Rody et al.
CLINICAL CANCER RESEARCH (2007)
Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas
Can E. Senkal et al.
MOLECULAR CANCER THERAPEUTICS (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
被撤回的出版物: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial (Retracted Article. See vol 12, pg 116, 2011)
[Anonymous]
LANCET ONCOLOGY (2007)
Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases
Nitai C. Hait et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Ceramide 1-phosphate/ceramide, a switch between life and death
Antonio Gomez-Munoz
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Sphingolipids in cancer: Regulation of pathogenesis and therapy
Besim Ogretmen
FEBS LETTERS (2006)
LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity
Yukiko Mizutani et al.
BIOCHEMICAL JOURNAL (2006)
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
JA Foekens et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants
T van Hall et al.
NATURE MEDICINE (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
When do lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis
Yael Pewzner-Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor
S Lahiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mammalian Lass6 and its related family members regulate synthesis of specific ceramides
Y Mizutani et al.
BIOCHEMICAL JOURNAL (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia
ZW Xu et al.
JOURNAL OF LIPID RESEARCH (2005)
Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer
YX Wang et al.
LANCET (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas
S Koybasi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Novel ceramide analogs as potential chemotherapeutic agents in breast cancer
AP Struckhoff et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors
C Riebeling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells
K Venkataraman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ceramide levels are inversely associated with malignant progression of human glial tumors
L Riboni et al.
GLIA (2002)
Identification of high risk breast-cancer patients by gene expression profiling
A Ahr et al.
LANCET (2002)
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line
S Mehta et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
The role of meta-analyses in assessing cancer treatments
R Sylvester et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
